Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MIRM
#1168
Mirum Pharmaceuticals, Inc. Common Stock
92.290
0
+0.51%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.51%
Changement Mensuel
-8.40%
Evolution sur 6 mois
+31.60%
Changement Annuel
+31.60%
Clôture Précédente
91.820
0
Open
92.110
0
Bid
Ask
Low
92.110
0
High
92.290
0
Volume
133
Marchés
Actions des Marchés US
Soins de Santé
MIRM
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
48 M
49.01 M
49.53 M
50.24 M
51.39 M
60.34 M
—
Valuation ratios
Enterprise value
1.65 B
1.8 B
2.02 B
2.33 B
3.49 B
4.47 B
12.3 B
Price to earnings ratio
-19.02
-22.35
-27.98
-42.06
-87.27
-168.06
-325.38
Price to sales ratio
5.81
5.83
5.69
5.76
7.9
7.61
26.96
Price to cash flow ratio
53.17
190.32
-707.58
282.57
92.45
71.03
-261.54
Price to book ratio
1.88
8.71
2.34
2.61
3.71
12.6
21.26
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.02
-0.04
-0.02
-0.01
0
-0.01
-0.03
Return on equity %
-0.06
-0.11
-0.06
-0.02
0.01
-0.02
-0.09
Return on invested capital %
-17.15
-32.72
-16.55
-5.25
-2.74
-10.19
-34.74
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-14.03
-24.36
-13.61
-3.9
-1.96
-3.07
-22.53
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-15.75
-23.93
-13.15
-4.59
2.18
-3.85
-19.4
Liquidity ratios
Quick ratio
3.15
2.93
3.04
2.97
3.16
2.55
11.73
Current ratio
3.34
3.1
3.22
3.13
3.31
2.67
12.33
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.14
0.15
0.16
0.18
0.18
0.18
0.7
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.46
0.46
0.45
0.43
0.39
0.37
1.63
Long term debt to total equity ratio
1.33
1.37
1.32
1.21
1.06
0.98
4.58
Per share metrics
Operating cash flow per share
0.08
-0.11
-0.04
0.24
0.7
0.12
1.02
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
5.95
4.68
5.68
6.12
6.59
7.64
26.03
Net current asset value per share
8.09
8.27
8.4
9.12
9.31
10.95
37.78
Tangible book value per share
-0.5
-0.51
-0.22
0.35
1.06
1.07
2.26
Working capital per share
5.67
5.6
5.79
6.21
6.5
6.85
25.35
Book value per share
4.86
4.75
4.77
5.13
5.12
6.27
21.3
Nouvelles
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Leerink将Mirum Pharmaceuticals目标价下调至118美元
Evercore ISI重申Mirum Pharmaceuticals股票评级为跑赢大盘
Leerink cuts Mirum Pharmaceuticals stock price target to $118
Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform
Mirum Pharmaceuticals股价因研发支出前景下跌,RBC重申跑赢大盘评级
Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)
Citizens因估值原因下调Mirum Pharmaceuticals目标价
Citizens cuts Mirum Pharmaceuticals stock price target on valuation
Mirum Pharmaceuticals Q4 每股收益 逊于预期, 营收 超出预期